Quantcast
Channel: WN.com - Articles related to Actelion to enter Phase II clinical development with new dual orexin receptor antagonist in patients with insomnia (Actelion Ltd)
Viewing all articles
Browse latest Browse all 480

Cardio-Oncology Patients in the Cardiac Catheterization Laboratory (American College of Cardiology Foundation)

$
0
0
(Source: American College of Cardiology Foundation) Patients with cancer have greatly improved survival with current chemotherapy and radiation therapies. This has resulted in many patients developing heart disease that may need to be diagnosed or treated in the cardiac catheterization laboratory. The following are key points to remember from this expert consensus document on management of cardio-oncology patients in the catheterization laboratory: In addition to known effects on ventricular function, certain chemotherapeutic agents may injure the vascular system, causing acute endothelial damage, abnormal vasoreactivity, vasospasm, and platelet activation and aggregation. Clinical...

Viewing all articles
Browse latest Browse all 480

Trending Articles



<script src="https://jsc.adskeeper.com/r/s/rssing.com.1596347.js" async> </script>